STOCK TITAN

[Form 4] Utz Brands, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Positive)
Form Type
4
Rhea-AI Filing Summary

Roger K. Deromedi, a director of Utz Brands, Inc. (UTZ), exercised 2,400,000 warrants on a cashless basis on 08/08/2025 under the Warrant Agreement, generating shares determined by the agreement's formula. As part of the cashless exercise, 1,966,653 shares were withheld to satisfy consideration. Following the reported transactions, the filing shows 4,483,389 shares beneficially owned indirectly through the Roger K. Deromedi Revocable Trust.

The filing lists additional holdings: 1,000,000 shares in a 2024 GRAT, 461,401 in a 2021 GRAT, 409,369 in a 2024 GRAT 1, and 360,000 held by an irrevocable generation-skipping trust (for which the reporting person disclaims beneficial ownership). The exercised warrants were exercisable immediately and expire on 08/28/2025.

Roger K. Deromedi, amministratore di Utz Brands, Inc. (UTZ), ha esercitato 2,400,000 warrant in modalità cashless il 08/08/2025 ai sensi del Warrant Agreement, ottenendo azioni calcolate secondo la formula prevista dall'accordo. Come parte dell'esercizio cashless, 1,966,653 azioni sono state trattenute a titolo di corrispettivo. A seguito delle operazioni segnalate, il deposito indica 4,483,389 azioni possedute indirettamente tramite il Roger K. Deromedi Revocable Trust.

Il deposito elenca ulteriori partecipazioni: 1,000,000 azioni in un GRAT 2024, 461,401 in un GRAT 2021, 409,369 in un GRAT 2024 1 e 360,000 detenute da un irrevocable generation-skipping trust (di cui la persona che presenta il rapporto nega la titolarità beneficiaria). I warrant esercitati erano immediatamente esercitabili e scadono il 08/28/2025.

Roger K. Deromedi, director de Utz Brands, Inc. (UTZ), ejerció 2,400,000 warrants en forma cashless el 08/08/2025 conforme al Warrant Agreement, generando acciones determinadas por la fórmula del acuerdo. Como parte del ejercicio sin pago en efectivo, se retuvieron 1,966,653 acciones para satisfacer la contraprestación. Tras las transacciones informadas, la presentación muestra 4,483,389 acciones poseídas indirectamente a través del Roger K. Deromedi Revocable Trust.

La presentación enumera participaciones adicionales: 1,000,000 acciones en un GRAT 2024, 461,401 en un GRAT 2021, 409,369 en un GRAT 2024 1 y 360,000 mantenidas por un irrevocable generation-skipping trust (sobre el cual la persona informante renuncia a la titularidad beneficiaria). Los warrants ejercidos eran ejercitables de inmediato y expiran el 08/28/2025.

Roger K. Deromedi는 Utz Brands, Inc. (UTZ)의 이사로서 08/08/2025에 현금지급 없이(cashless) 2,400,000개의 워런트를 Warrant Agreement에 따라 행사하여 해당 계약의 공식으로 산정된 주식을 취득했습니다. 현금 비지급 행사로서 1,966,653주가 보상금 충당을 위해 원천징수되었습니다. 보고된 거래 이후 제출서류에는 Roger K. Deromedi Revocable Trust를 통해 간접적으로 4,483,389주를 실질적으로 보유하고 있는 것으로 기재되어 있습니다.

제출서류에는 추가 보유 내역으로 1,000,000주(2024 GRAT), 461,401주(2021 GRAT), 409,369주(2024 GRAT 1) 및 보고인이 실질적 소유권을 부인하는 불가역적 generation-skipping trust에 360,000주가 기재되어 있습니다. 행사된 워런트는 즉시 행사 가능했으며 08/28/2025에 만료됩니다.

Roger K. Deromedi, administrateur d'Utz Brands, Inc. (UTZ), a exercé 2,400,000 warrants sans paiement en espèces le 08/08/2025 en vertu du Warrant Agreement, obtenant des actions déterminées selon la formule prévue par l'accord. Dans le cadre de l'exercice sans numéraire, 1,966,653 actions ont été retenues pour régler la contrepartie. À la suite des opérations déclarées, le dépôt indique 4,483,389 actions détenues indirectement via le Roger K. Deromedi Revocable Trust.

Le dépôt énumère des détentions supplémentaires : 1,000,000 actions dans un GRAT 2024, 461,401 dans un GRAT 2021, 409,369 dans un GRAT 2024 1, et 360,000 détenues par un trust irrévocable generation-skipping (dont la personne déclarante décline la qualité de bénéficiaire). Les warrants exercés étaient immédiatement exerçables et expirent le 08/28/2025.

Roger K. Deromedi, ein Direktor von Utz Brands, Inc. (UTZ), übte am 08/08/2025 2,400,000 Warrants auf cashless-Basis gemäß dem Warrant Agreement aus und erhielt Aktien, die nach der im Vertrag festgelegten Formel berechnet wurden. Im Rahmen der cashless-Ausübung wurden 1,966,653 Aktien einbehalten, um die Gegenleistung zu erfüllen. Nach den gemeldeten Transaktionen weist die Meldung 4,483,389 Aktien aus, die indirekt über den Roger K. Deromedi Revocable Trust wirtschaftlich gehalten werden.

Die Meldung listet weitere Bestände auf: 1,000,000 Aktien in einem 2024 GRAT, 461,401 in einem 2021 GRAT, 409,369 in einem 2024 GRAT 1 und 360,000, die von einem unwiderruflichen generation-skipping trust gehalten werden (dessen wirtschaftlichen Eigentum die meldende Person verneint). Die ausgeübten Warrants waren sofort ausübbar und laufen am 08/28/2025 ab.

Positive
  • Maintains significant indirect ownership: Filing shows 4,483,389 shares indirectly held through the Revocable Trust after the exercise.
  • Warrants exercised under agreement: The 2,400,000 warrants were exercised pursuant to the Warrant Agreement on a cashless basis, completing the contractual conversion process.
Negative
  • Shares withheld on exercise: 1,966,653 shares were withheld to satisfy the cashless exercise, reducing the net new shares received from the exercise.
  • Some shares held outside reporting person's beneficial ownership: The reporting person disclaims beneficial ownership of 360,000 shares held in an irrevocable trust where the spouse holds voting and dispositive power.

Insights

TL;DR: Director exercised 2.4M warrants cashless, with ~1.97M shares withheld; maintains material indirect stake of 4.48M shares.

The Form 4 documents a cashless exercise of 2,400,000 private-placement warrants on 08/08/2025, with 1,966,653 shares withheld to satisfy the exercise consideration. Table entries show 4,483,389 shares indirectly owned via the Revocable Trust after the transactions. The filing also enumerates multiple trust-held blocks totaling sizable share counts, and notes the warrants expire on 08/28/2025. This is a routine Section 16 disclosure of insider conversion activity rather than an operational disclosure.

TL;DR: Insider conversion and trust holdings reinforce continued insider ownership and control through multiple trusts; disclosures are standard and specific.

The reporting person is identified as Roger K. Deromedi, a director, and the filing explicitly states he holds voting and dispositive power over several trusts that own Company shares. The Form 4 details the mechanics: cashless warrant exercise per the Warrant Agreement, shares withheld (1,966,653), and remaining indirect holdings. The filing includes a disclaimer of beneficial ownership for 360,000 shares held in an irrevocable trust where the spouse holds voting/dispositive power. All material items presented are procedural insider ownership disclosures.

Roger K. Deromedi, amministratore di Utz Brands, Inc. (UTZ), ha esercitato 2,400,000 warrant in modalità cashless il 08/08/2025 ai sensi del Warrant Agreement, ottenendo azioni calcolate secondo la formula prevista dall'accordo. Come parte dell'esercizio cashless, 1,966,653 azioni sono state trattenute a titolo di corrispettivo. A seguito delle operazioni segnalate, il deposito indica 4,483,389 azioni possedute indirettamente tramite il Roger K. Deromedi Revocable Trust.

Il deposito elenca ulteriori partecipazioni: 1,000,000 azioni in un GRAT 2024, 461,401 in un GRAT 2021, 409,369 in un GRAT 2024 1 e 360,000 detenute da un irrevocable generation-skipping trust (di cui la persona che presenta il rapporto nega la titolarità beneficiaria). I warrant esercitati erano immediatamente esercitabili e scadono il 08/28/2025.

Roger K. Deromedi, director de Utz Brands, Inc. (UTZ), ejerció 2,400,000 warrants en forma cashless el 08/08/2025 conforme al Warrant Agreement, generando acciones determinadas por la fórmula del acuerdo. Como parte del ejercicio sin pago en efectivo, se retuvieron 1,966,653 acciones para satisfacer la contraprestación. Tras las transacciones informadas, la presentación muestra 4,483,389 acciones poseídas indirectamente a través del Roger K. Deromedi Revocable Trust.

La presentación enumera participaciones adicionales: 1,000,000 acciones en un GRAT 2024, 461,401 en un GRAT 2021, 409,369 en un GRAT 2024 1 y 360,000 mantenidas por un irrevocable generation-skipping trust (sobre el cual la persona informante renuncia a la titularidad beneficiaria). Los warrants ejercidos eran ejercitables de inmediato y expiran el 08/28/2025.

Roger K. Deromedi는 Utz Brands, Inc. (UTZ)의 이사로서 08/08/2025에 현금지급 없이(cashless) 2,400,000개의 워런트를 Warrant Agreement에 따라 행사하여 해당 계약의 공식으로 산정된 주식을 취득했습니다. 현금 비지급 행사로서 1,966,653주가 보상금 충당을 위해 원천징수되었습니다. 보고된 거래 이후 제출서류에는 Roger K. Deromedi Revocable Trust를 통해 간접적으로 4,483,389주를 실질적으로 보유하고 있는 것으로 기재되어 있습니다.

제출서류에는 추가 보유 내역으로 1,000,000주(2024 GRAT), 461,401주(2021 GRAT), 409,369주(2024 GRAT 1) 및 보고인이 실질적 소유권을 부인하는 불가역적 generation-skipping trust에 360,000주가 기재되어 있습니다. 행사된 워런트는 즉시 행사 가능했으며 08/28/2025에 만료됩니다.

Roger K. Deromedi, administrateur d'Utz Brands, Inc. (UTZ), a exercé 2,400,000 warrants sans paiement en espèces le 08/08/2025 en vertu du Warrant Agreement, obtenant des actions déterminées selon la formule prévue par l'accord. Dans le cadre de l'exercice sans numéraire, 1,966,653 actions ont été retenues pour régler la contrepartie. À la suite des opérations déclarées, le dépôt indique 4,483,389 actions détenues indirectement via le Roger K. Deromedi Revocable Trust.

Le dépôt énumère des détentions supplémentaires : 1,000,000 actions dans un GRAT 2024, 461,401 dans un GRAT 2021, 409,369 dans un GRAT 2024 1, et 360,000 détenues par un trust irrévocable generation-skipping (dont la personne déclarante décline la qualité de bénéficiaire). Les warrants exercés étaient immédiatement exerçables et expirent le 08/28/2025.

Roger K. Deromedi, ein Direktor von Utz Brands, Inc. (UTZ), übte am 08/08/2025 2,400,000 Warrants auf cashless-Basis gemäß dem Warrant Agreement aus und erhielt Aktien, die nach der im Vertrag festgelegten Formel berechnet wurden. Im Rahmen der cashless-Ausübung wurden 1,966,653 Aktien einbehalten, um die Gegenleistung zu erfüllen. Nach den gemeldeten Transaktionen weist die Meldung 4,483,389 Aktien aus, die indirekt über den Roger K. Deromedi Revocable Trust wirtschaftlich gehalten werden.

Die Meldung listet weitere Bestände auf: 1,000,000 Aktien in einem 2024 GRAT, 461,401 in einem 2021 GRAT, 409,369 in einem 2024 GRAT 1 und 360,000, die von einem unwiderruflichen generation-skipping trust gehalten werden (dessen wirtschaftlichen Eigentum die meldende Person verneint). Die ausgeübten Warrants waren sofort ausübbar und laufen am 08/28/2025 ab.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DEROMEDI ROGER K

(Last) (First) (Middle)
C/O UTZ BRANDS, INC.
900 HIGH STREET

(Street)
HANOVER PA 17331

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Utz Brands, Inc. [ UTZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/08/2025 M(1) 2,400,000 A $11.5(1) 4,483,389 I See Footnote(2)
Class A Common Stock 08/08/2025 F(3) 1,966,653 D (3) 2,516,736 I See Footnote(2)
Class A Common Stock 1,000,000 I See Footnote(4)
Class A Common Stock 461,401 I See Footnote(5)
Class A Common Stock 360,000 I See Footnote(6)
Class A Common Stock 35,052 D
Class A Common Stock 409,369 I See Footnote(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants to purchase Class A Common Stock $11.5 08/08/2025 M(1) 2,400,000 (8) (8) Class A Common Stock 2,400,000 (1) 0 I See Footnote(2)
Explanation of Responses:
1. Reflects the exercise of 2,400,000 warrants to purchase shares of Class A common stock of Utz Brands, Inc. ("Issuer") on a cashless basis pursuant to the Warrant Agreement, dated as of October 4, 2018 (the "Warrant Agreement"), by and between Collier Creek Holdings ("Collier Creek") and Continental Stock Transfer & Trust Company ("CST"), as assumed by the Issuer pursuant to that certain Assignment and Assumption Agreement, dated as of February 22, 2022, by and among the Issuer, CST, Equinity Trust Company ("Equinity") and the Consenting Holders (as defined therein). The number of shares of Class A common stock issuable upon exercise of the warrants was determined in accordance with section 3.3.1(c) of the Warrant Agreement.
2. The securities are held by the Roger K. Deromedi Revocable Trust 2/11/2000 Amended and Restated 11/09/2011 (the "Revocable Trust"). The Reporting Person holds voting and dispositive power over the Revocable Trust.
3. Reflects the shares of Class A common stock "withheld" in connection with the cashless exercise. Pursuant to Section 3.3.1(c) of the Warrant Agreement, the price was calculated as the average last reported sale price of the shares for the ten trading days ending on the third trading day prior to the date on which notice of exercise of the private placement warrant was sent to the warrant agent.
4. The securities are held by the Roger K Deromedi Irrevocable Grantor Retained Annuity Trust (GRAT) u/a/d 11/19/2024 (the "2024 GRAT 2"). The Reporting Person holds voting and dispositive power over the 2024 GRAT 2.
5. The securities are held by the Roger K. Deromedi Irrevocable Grantor Retained Annuity Trust dated 11/01/2021 (the "2021 GRAT"). The reporting Person holds voting and dispositive power over the 2021 GRAT.
6. The securities are held by the Roger K. Deromedi Irrevocable Generation Skipping Trust dated October 1, 2020, Sandra E. Deromedi, Trustee, FBO Sandra E. Deromedi (the "Irrevocable Trust"). To the extent permitted under applicable law, the Reporting Person disclaims beneficial ownership of the shares held by the Irrevocable Trust. The Reporting Person's spouse holds voting and dispositive power over the Irrevocable Trust.
7. The securities are held by the The Roger K. Deromedi Irrevocable Grantor Retained Annuity Trust (GRAT) u/a/d 2/22/2024 (the "2024 GRAT 1"). The Reporting Person holds voting and dispositive power over the 2024 GRAT 1.
8. The warrants are exercisable at any time and expire on August 28, 2025 or earlier upon redemption or the liquidation of the Issuer.
Remarks:
/s/ Theresa R. Shea, as attorney-in-fact for Roger K. Deromedi 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Utz (UTZ) director Roger K. Deromedi report on Form 4?

The Form 4 reports a cashless exercise of 2,400,000 warrants on 08/08/2025, with 1,966,653 shares withheld and 4,483,389 shares indirectly owned thereafter.

How many shares were withheld in the cashless warrant exercise for UTZ?

The filing states that 1,966,653 shares were withheld in connection with the cashless exercise.

When do the exercised warrants expire for the UTZ filing?

The warrants are exercisable at any time and expire on 08/28/2025, or earlier upon redemption or liquidation of the issuer.

Which trusts hold Utz shares for Roger K. Deromedi according to the filing?

The filing identifies the Roger K. Deromedi Revocable Trust, a 2024 GRAT 2 (1,000,000 shares), a 2024 GRAT 1 (409,369), a 2021 GRAT (461,401), and an irrevocable generation-skipping trust (360,000), among others.

Does Roger K. Deromedi retain voting and dispositive power over the trust holdings?

Yes. The Form 4 states the reporting person holds voting and dispositive power over several trusts, including the Revocable Trust and multiple GRATs, except where a disclaimer is stated.
Utz Brands Inc

NYSE:UTZ

UTZ Rankings

UTZ Latest News

UTZ Latest SEC Filings

UTZ Stock Data

1.10B
71.55M
17.33%
94.39%
7.37%
Packaged Foods
Miscellaneous Food Preparations & Kindred Products
Link
United States
HANOVER